De las innovaciones tecnológicas a la gammagrafía mamaria

Otero E. Reseñas bibliográficas: la medicina nuclear. Temprana historia y reminiscencias personales. Medicina 2002;24(3):67-76.

Gomez A. Los procesos oncológicos acaparan la mitad de la actividad de medicina nuclear. Sociedad Española de Medicina Nuclear. Congreso de la Socidad Española de Medicina Nuclear 22, 2001 junio 13-16, Ciudad Real, España. Disponible en URL: http://www.diariomedico.com/mnuclear/n150601.html

Crane P, Laliberte R, Heminway S, Thoolen M, Orlandi C. Effect of mitochondrial viability and metabolism on technetium-99m-sestamibi myocardial retention. Eur J Nucl Med 1993;20:20-25.

https://doi.org/10.1007/BF02261241

Clifford EJ, Lugo-Zamudio C. Scintimammography in the diagnosis of breast cancer. Am J Surg 1996;172:483-486.

https://doi.org/10.1016/S0002-9610(96)00225-5

Palmedo H, Grunwald F, Bender H, Schomburg A, Mailman P, Krebs D, et al. Scintimammography with techetium-99m methoxyisobutylisonitrile: comparison with mammography and magnetic resonance imaging. Eur J Nucl Med 1996;23(8):940-946.

https://doi.org/10.1007/BF01084368

Ballinger JR, Hua HA, Berry BW, Firby P, Boxen I. Tc-99m-sestamibi as an agent for imaging P-glycoprotein-mediated multi-drug resistance: in vitro and in vivo studies in a rat breast tumour cell line and its doxorubicin-resistant variant. Nucl Med Commun 1995;16:253-257.

https://doi.org/10.1097/00006231-199504000-00156